News & Updates

Show Multimedia Only

Adjuvant cisplatin-gemcitabine ups PFS vs cisplatin-fluorouracil in N2–3 NPC after cCRT

06 Jun 2023 by

In Chinese patients with stage N2–3 nasopharyngeal carcinoma (NPC) who have completed concurrent chemoradiotherapy (cCRT), adjuvant cisplatin-gemcitabine significantly improves progression-free survival (PFS) vs current standard of care (SoC) with adjuvant cisplatin-fluorouracil, according to a phase III trial at four cancer centres in China that was reported at ASCO 2023.

Adjuvant cisplatin-gemcitabine ups PFS vs cisplatin-fluorouracil in N2–3 NPC after cCRT

06 Jun 2023

Camrelizumab plus apatinib and temozolomide delivers in advanced acral melanoma

05 Jun 2023

The combination of camrelizumab plus apatinib and temozolomide appears to be beneficial in the first-line treatment of advanced acral melanoma, with the majority of the patients showing response and an acceptable safety profile, according to the results of a phase II study.

Camrelizumab plus apatinib and temozolomide delivers in advanced acral melanoma

05 Jun 2023

Sexual dysfunction in young cancer survivors tied to fatigue, worse sleep

04 Jun 2023

Female young adult cancer survivors (YACS) with sexual dysfunction show higher levels of fatigue, have worse sleep, and experience more frequent severe pain compared to those without sexual dysfunction, reports a study.

Sexual dysfunction in young cancer survivors tied to fatigue, worse sleep

04 Jun 2023

Fruit and vegetable intake lowers endometrial cancer risk

02 Jun 2023

Eating fruits and vegetables may help reduce the risk of endometrial cancer, suggests a recent study, noting that specific kinds of fruits and vegetables must be recommended based on their outstanding bioactive components.

Fruit and vegetable intake lowers endometrial cancer risk

02 Jun 2023

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

New drug applications approved by US FDA as of 16-31 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

Cancer incidence uncommon among low-risk pancreatic cysts during extended surveillance

31 May 2023

Low-risk branch duct intraductal papillary mucinous neoplasms (BD-IPMNs) appear to have a positive outlook, with the results of a recent meta-analysis showing that the incidence of advanced neoplasia during extended surveillance is low.

Cancer incidence uncommon among low-risk pancreatic cysts during extended surveillance

31 May 2023

Innovation in Breast Cancer treatment

30 May 2023

In 2020, cases of breast cancer breached 2 million,¹ making it the most frequently diagnosed cancer in women worldwide. The increase in cases was attributed to lifestyle changes and better screening tools. Survival in the present day still heavily depends on staging and the molecular subtype. Molecular subtypes have provided breakthrough insights into new treatment strategies over the years and management have continued to evolve as more about the disease is understood.

During the Philippine Society of Medical Oncology (PSMO) 36th annual convention, women’s health was once again highlighted in the lecture “Reimagine the Future of Breast Cancer.” Dr Josephine Tolentino, Dr See Hui Ti, Dr Ellie May Villegas and Ms Aileen Antolin shared their insights during the session which was moderated by Dr Pamela Padtu.

Innovation in Breast Cancer treatment

30 May 2023

Functional surgery delivers amputation-free benefit in nail unit melanoma

29 May 2023

Patients who have nail unit melanoma (NUM) with a Breslow thickness (BT) of <0.8 mm may benefit from functional surgery, which offers an amputation-sparing advantage, suggests a recent study.